USMLE OB
Quiz yourself by thinking what should be in
each of the black spaces below before clicking
on it to display the answer.
Help!
|
|
||||
|---|---|---|---|---|---|
| MC cause of DIC in preg | abruptio placenta
🗑
|
||||
| on US what measurements most accurate for est GA, how accurate | 8-12 wks use crown rump (+/-5), 12-18 use biparietal (+/-7)
🗑
|
||||
| general guidelines for accuracy of US at difft trimesters for dating preg | <20wk US considered pretty accurate, 1st tri can be off by 1wk, 2nd tri off by 2wk, 3rd tri off by 3wks
🗑
|
||||
| determination of pregnancy--cut off hCG | 25mU/ml
🗑
|
||||
| when gestational sac visible | 5wks
🗑
|
||||
| how AFI measured | deepest vertical pockets of amniotic fluid in 4 quadrants
🗑
|
||||
| how polyhydramnios defined? Oligo? | AFI>25 it's poly, if <5 it's oligo
🗑
|
||||
| where is top of fundus if 16wk? 20wk? | 1/2 pubis to umbilicus for 16wk, at umbilicus for 20wk
🗑
|
||||
| for karyotyping when is chorionic villus sampling done? Amnio? Percut umbil blood sample? Risk for ea? | CVS=9-12, 0.7%; amnio 15-20, risk 0.5%; PBUS >20wks risk 1-2%
🗑
|
||||
| risk of chromo abnlty in 35yo? Risk of Tri21? | 1:365; 1:180
🗑
|
||||
| genetics of preg losses, % chromo abnl, what type | 50% spont abortions have abnl chromo, 50% autosomal trisomies, 20% turners
🗑
|
||||
| ex of XL dominant where dz in females & males | hypophosphatemic rickets
🗑
|
||||
| ex of XL dominant where dz in females and fatal in males | incontinentia pigmenta, focal dermal hypoplasia
🗑
|
||||
| if child w CHD what risk of 2nd | overall risk is 1%, 2nd child is 2%
🗑
|
||||
| if child w cleft lip, what risk of 2nd? If 2 children w cleft lip what risk of 3rd | 4%, 10%
🗑
|
||||
| name major products of 3 germ layers | Ecto=CNS/PNS, organs of seeing/hearing, integument (skin, hair, nails); Meso=mscle, cartilage, CVS, GU; Endo=lining GI and respir
🗑
|
||||
| role of paramesonephric/mullerian duct, how develops in males and females | Present in all embyros. Y chrom induces gonades to secrete mullerian inhib factor which causes mullerian duct to involute. In females the mullerian duct forms fallopian tubes, uterus, cervix, prox vagina
🗑
|
||||
| role of mesonephric/Wolffian duct, how develops in males and females | Need androgens (and working R) to continue to form vas deferens, seminal vesicles, epididymis, and efferent ducts. In females w/o androgens this involutes.
🗑
|
||||
| how female ext genitalia develop | w/o hormones labia majora, minora, clitoris and distal vagina form
🗑
|
||||
| how male ext genitalia develop | Need androgen stimulation for penis and scrotum. W/o androgen R will difft towards female ext genitalia
🗑
|
||||
| describe testosterone metabolism as relates to virilization ext genitalia | Leydig cells secrete testosterone (maintains Wolffian duct), 5 alpha-reductase converts it into dihydrotestosterone (virilizes external genitalia)
🗑
|
||||
| describe FDA categorization of Rx during preg | A-no risk, B-may have adverse effects in animals but no evidence in humans, C-risk cannot be r/o, X-contraindicated
🗑
|
||||
| describe phenytoin abnlties in fetus | IUGR, epicanthal folds, saddle shaped nose, oral clefts, MR, microcephaly, nail hypoplasia, CHD
🗑
|
||||
| describe cocaine abnlties in fetus | placental abruption, preterm, IVH, IUGR (also bowel atresia?)
🗑
|
||||
| describe marijuana abnlties in fetus | preterm, no abnlties
🗑
|
||||
| describe risks for radiation | : min risk if <5rad, intermediate 5-10, high risk >10rad
🗑
|
||||
| describe EtOH abnlties in fetus | IUGR, midfacial hypoplasia, short palpebral fissures, CHD, MR, jt abnlties
🗑
|
||||
| describe istoretinoin abnlties in fetus | congenital deafness, microtia, CNS defects, CHD
🗑
|
||||
| describe trimethadione abnlties in fetus | short upturned nose, slanted eyebrows, CHD, IUGR, MR
🗑
|
||||
| describe bHCG structure, what produces it, and how levels change in preg | 2 subunits, alpha is like LH, FSH, thyroptropin; produced by syncytiotrophoblast, first detected d10 after fertilization, peaks 9-10 wks, plateaus 20-22. Should dble q2-3 days early on
🗑
|
||||
| roles 3 bHCG | maintain corpus luteum production of prog until placenta does that; regulates steroid biosyn in placenta and fetal adrenal gland; stimulates testost in fetal male testis
🗑
|
||||
| describe HPL structure and how levels change in preg | like GH and prolactin in structure, levels parallel placenta grwth and keep rising throughout preg
🗑
|
||||
| describe progest--what produces it, and how levels change in preg | After ovulation by luteal cells of corpus luteum for endomet secret changes for implant. By corpus luteum until 7-9 wks when both corpus luteum and placenta produce, >9wks just placenta. Later preg induces immune tolerance and prevent myometrial cxns.
🗑
|
||||
| high levels bHCG can indicate? Low levels? | mltpls, hydatiform mole, choriocarcinoma, embryonal carinoma; ectopic, threatened/missed abortion
🗑
|
||||
| describe estradiol production, when high in life | MC form during nonpreg reproductive years. Cholesterol à androgens in follicular theca cells, diffuse into follcular granulosa cells, where aromatase androgens à estradiol
🗑
|
||||
| describe estriol production, when high in life | estogen during preg. DHEA-S from fetal adrenal gland à estriol by sulfatase in placenta
🗑
|
||||
| describe estrone production, when high in life | estrogen during menopause. Adrenal adnrostenedione à estrone by peripheral adipose
🗑
|
||||
| what facial lesion assoc w preg | Chloasma-blotchy pigment of nose and face
🗑
|
||||
| Chadwick sign? | Chadwick sign=bluish/purple of vagina and cervix from incrsd vascularity
🗑
|
||||
| what position of preg women will make her CO highest | L lateral (pressure off of IVC)
🗑
|
||||
| what happens to CVP, fem venous P, and PVR in preg | CVP unchanged, femoral venous P incrses 2-3x (varicose veins, hemorrhoids); PVR declines 30% (bc PVR=BP/CO and BP decrses and CO incrses
🗑
|
||||
| define 1st, 2nd, 3rd tri | 1-12; 13-26; 27-40
🗑
|
||||
| define abortion | preg loss or termination <20wks
🗑
|
||||
| Antepartum death | Antepartum death: fetal death 20wks-start of labor
🗑
|
||||
| Intrapartum death | Intrapartum death: fetal death during labor
🗑
|
||||
| Fetal death: | Fetal death: fetal death 20wks-birth (incl antepartum and intrapartum)
🗑
|
||||
| Perinatal death | Perinatal death: death 20wks-28 days of life
🗑
|
||||
| Neonatal death | Neonatal death: death birth-28 days of life
🗑
|
||||
| Infant death | Infant death: birth-1yo
🗑
|
||||
| preterm | 20-37wls
🗑
|
||||
| which mortality rates are per TOTAL births? Whch per LIVE births? | Fetal & perinatal mortality is per total births, neonatal, maternal & infant mortality is per live births
🗑
|
||||
| define fertility rate | live birth per 1000 women 15-45yo
🗑
|
||||
| define birth rate | Birth rate-live births per 1000 total population
🗑
|
||||
| define Gs, Ps, As | G=
🗑
|
||||
| check ups throughout preg | q1mo until 30wks, q 2-3wks 30-36wks, q1wk >36wks
🗑
|
||||
| Maternal death define. MC cause | Maternal death: during preg or within 90d (MC embolism
🗑
|
||||
| define lightening, when occur | descent of fetal head into pelvis, easier maternal breathing but pelvic pressure. 36wks in primagravida
🗑
|
||||
| nml wgt gain in preg | 5-8lbs in 1st tri, then 1lb/wk >20wks
🗑
|
||||
| causes low plts in preg | ITP or preg induced thrombocytopenia (DIC is rare)
🗑
|
||||
| what labs need drawn on first prenatal (not incl infxs) | Blood type, Rh, Ab screen (indirect Coombs), Sickle cell, CBC, UA/Ucx
🗑
|
||||
| what infxs labs need drawn on first prenatal | rubella, syphilis, HBsAg, HIV (requires consent), GC/Chlamydia, TB
🗑
|
||||
| in addtl to labs on first prenatal visit, what other lab/exam need to do | pap smear
🗑
|
||||
| determination of pregnancy--cut off hCG | 25mU/ml
🗑
|
||||
| how polyhydramnios defined? Oligo? | AFI>25 it's poly, if <5 it's oligo
🗑
|
||||
| how dx antiphospholipid syndrome | need 1 of history: venous thrombosis, PE, stroke, reptd preg losses, fetal demise, and 1 of labs: cardiolipin Abs, lupus anticoag, incrsd PTT
🗑
|
||||
| what labs indicate anti phospholipid syndrome | cardiolipin Abs, lupus anticoag, incrsd PTT
🗑
|
||||
| what are screening tools for Downs | 1st tri=PAPP, nuchal translucency, and mAFP, 2nd tri=triple screen/quad screen
🗑
|
||||
| causes of high MSAFP | neural tube, ventral wall, renal…twins and placental bleeding gives false high
🗑
|
||||
| what quad screen would suggest Downs | hi bHCG and inhibin, low MSAFP, estriol
🗑
|
||||
| what PAPP value suggests Downs | low along w high bHCG
🗑
|
||||
| glucola amt and when can dx with frank GDM w/o 3hr | 50g glucose, if blood glucose in 1hr >140 is cut off do 3hr; can dx w/o 3hr if single fasting 110 or grtr or was 200 on glucola
🗑
|
||||
| amt of glu given and cut offs for 3hr GTT | 100g given, cut offs: 95/180/155/140 [only need 2 abnml]
🗑
|
||||
| when test for GDM | 24-28wks
🗑
|
||||
| if tri21 or tri18 screen is + what do? | amnio for karyo
🗑
|
||||
| when check for anemia? What cut off? | 24-28wks, Hb<10
🗑
|
||||
| MC genetic cause of Downs? 2nd | meiotic nondisjunction (even if h/o on dad's side or smthg), 3% are inherited Robertsonian translocation
🗑
|
||||
| describe reactive nonstress testing, risk w/in next wk? | FHR accelerations 2 accel in 20 min, where accel are _10bpm lasting _10 sec [15&15 if >32wks] and <2min. Fetal death rate 1:3000 in the next week. If positive repeat wkly
🗑
|
||||
| how often is nonreactive NST false +? What are some causes for false + | fetus is asleep, immature or sedated, 80% are false positives, ie non hypoxemic
🗑
|
||||
| how f/u nonreactive NST | vibroacoustic stimulation; if still nonreactive need BPP
🗑
|
||||
| how is contraction stress test done, indications? | look at FHR in response to contractions, if not spontaneous cxns induce w oxytocin or nipple stimulation. Only use if BPP 4-6 and <36
🗑
|
||||
| describe a good CST, f/u? | good=negative=no late decelerations w 3 cxns in 10min; f/u CST wkly
🗑
|
||||
| positive CST? What does it mean? | Positive: repetitive late decelerations in 50% cxns, worrisome esp if tracing is also nonreactive…prompt delivery if 36wks! But 50% are false + when have good FHR variability
🗑
|
||||
| parameters in BPP | NST reactivity (accels), extremity tone (extension/flexion), breathing, gross body mvmts, AFI
🗑
|
||||
| how polyhydramnios defined? Oligo? | AFI>25 it's poly, if <5 it's oligo
🗑
|
||||
| how manage difft scores on BPP | 8-10 is reassuring; ii. 4-6 is equivocal should deliver if ≥36, or repeat in 12-24hr if <36 or do CST; 0-2 indicates fetus in jeopardy, deliver immediately no matter what age
🗑
|
||||
| what's modified BPP? How accurate is it v BPP? | NST + amniotic fluid index, predictive value almost as good as BPP
🗑
|
||||
| painLESS 3rd tri bleeding think | placenta previa
🗑
|
||||
| risk factors placenta previa | risk factors: mltpl gestation, prev placenta previa, multiparity, AMA
🗑
|
||||
| types placenta previa | low lying, partial, complete/total/central
🗑
|
||||
| when can do vaginal delivery of placenta previa | if lower placental edge >2cm from os
🗑
|
||||
| if <36 wks w placenta previa what do | Conservative in hospital observation if mom and baby are stable
🗑
|
||||
| if 36 wks and lung maturity confirmed how manage placenta previa | scheduled c/s if pt/baby stable
🗑
|
||||
| typical presentation of vasa previa | Often see when ROM results in acute vaginal bleeding and fetal bradycardia,
🗑
|
||||
| cause of vasa previa | rupture of vessels that cross membranes covering cervix, can be from velamentous insertion of umbilical cord or accessory/succenturiate placental lobe
🗑
|
||||
| risk factors for vasa previa | velamentous insertion of umbilical cord, accessory placental lobes, multiple gestations
🗑
|
||||
| risk factors for placenta previa | mltpl gestation, prev placenta previa, multiparity, AMA
🗑
|
||||
| define placenta accreta, key risk factor? | placenta grows into myometrium- prev c/s at risk for this (ie in area of scar)
🗑
|
||||
| MC cause of 3rd tri painful bleeding, 2nd MC | abruptio placenta, uterine rupture
🗑
|
||||
| describe pathophysiol of abruptio placenta | Hemorrhage into decidua basalis behind nmlly implanted placenta (ie not in lower uterine seg
🗑
|
||||
| risk factors abruptio placenta | HTN, trauma, cocaine, PROM, prev abruptio placentae
🗑
|
||||
| types of abruptio placenta, MC | overt/external (MC), concealed ie retroplacental
🗑
|
||||
| degrees of abruptio placenta | mild-moderate blood loss, no change FHT; moderate 25-50% separated, FHT shows tachy, decrsd var, or mild late decels; severe: abrupt sympt, FHT severe late decels, etc, severe DIC may occur
🗑
|
||||
| management abruptio placenta | emergent c/s if mom or baby in jeopardy, vaginal delivery if 36 wks and bleeding heavy but controlled, conservative if stable and <36 wks, bldg is min or decrsing and cxns subsiding
🗑
|
||||
| describe uterine rupture and difft types, how difft from uterine dehiscence | Complete separation of wall of uterus that can include the visceral peritoneum (complete) or not (incomplete) (difft from uterine dehiscence=gradual asympt separation of a uterine scar w/o bleeding)
🗑
|
||||
| key presentation of uterine rupture | painful, heavy bleeding w contracted uterus, non reassuring FHT
🗑
|
||||
| management uterine rupture | emergent c/s
🗑
|
||||
| risk factors uterine rupture | classic c/s scar (20x more likely than lower transverse), transmural myomectomy, excessive oxytocin
🗑
|
||||
| types of abortions (5) | threatened, missed, inevitable, incomplete, complete
🗑
|
||||
| describe threatened and missed abortions | threatened=bleeding only; missed=nonviable preg, no bleeding or dilation
🗑
|
||||
| tx for missed abortion | scheduled D&C or conservative waiting passage
🗑
|
||||
| describe inevitable abortion | heavy bleeding, dilation, NO passing of POC
🗑
|
||||
| woman comes in with heavy bleeding, passing of some pcs--what dx? What tx? | incomplete abortion if still cramping and bleeding, need emergent D
🗑
|
||||
| tx for inevitable abortion | emergent D
🗑
|
||||
| describe completed abortion | heavy bleeding, all POC have been passed and now cramping and bleeding minimal
🗑
|
||||
| how does fetal demise/death present <20wks, >20wks; how confirm dx | <20wk appears as lack of fundal grwth, later w decrsd fetal mvmt. Confirm w sonographic lack of cardiac mvmt
🗑
|
||||
| causes for fetal demise (7) | idiopathic (MC), placental, umbilical cord, fetal death, antiphospholipid, maternal trauma, DM macrosomiaoutgrowing placenta
🗑
|
||||
| placental causes for fetal demise | abruptio placenta, infxn not allowing O2 xchg, macrosomia in DM outgrowing placenta
🗑
|
||||
| how dx antiphospholipid syndrome | need 1 of history: venous thrombosis, PE, stroke, reptd preg losses, fetal demise, and 1 of labs: cardiolipin Abs, lupus anticoag, incrsd PTT
🗑
|
||||
| what labs indicate anti phospholipid syndrome | cardiolipin Abs, lupus anticoag, incrsd PTT
🗑
|
||||
| for fetal demise how determine how deliver | if <20 and don't want autopsy do D&E, otherwise do induction w vaginal PGE2 (if no DIC may want to wait few days to help family grieve)
🗑
|
||||
| tx fetal demise | **first r/o DIC (plt, d-dimer, fibrinogen, PT/PTT). DIC esp at risk if >2 wks--if DIC must delivery immed
🗑
|
||||
| w/u after fetal demise | can include cervical&placenta cultures, autopsy, karyotype, maternal blood for Kleihauer-Betke, total body xray for osteochondrodysplasia??
🗑
|
||||
| risk factors for dizygotic twins? Mono? | dizyg=race, geography, FMH, ovulation induction; monozyg no known
🗑
|
||||
| incidence of twin w spontaneous ovulation and fertility tx | 1:90 spontaneous, 1:10 if clomiphene, 1:3 if gonadotropins
🗑
|
||||
| when should accels become apparent | 30wks
🗑
|
||||
| key complications assoc mltpl gestat | 50% chance of premature delivery, 3x preE, 5x PTL, 5x c/s, placenta previa, PPH, nutritional, malpresentation (50%)
🗑
|
||||
| terminology of twins based on placenta | Monochorion (1 placenta)=monozygotic (identical), can be mono or diamnion; dichorionic can be mono or dizygotic
🗑
|
||||
| terminology of twins based on zygotes | Dizygotic MC (2/3), mltpl ovulation w 2 zygotes. ALWAYS dichorionic diamnionic; monozyg can be mono or di chorionic or amnionic
🗑
|
||||
| monozygotic based on when divided | 72hrs=dichor diamnion; 4-8d (blastocyst)=monochor diamnion, 9-12d=monochor monoamnion, >12=conjoined
🗑
|
||||
| which twins at risk for twin twin transfusion? Cord entanglement | twin-twin=monochorion (mono or diamnion); cord=monochor monoamnion
🗑
|
||||
| antepartum management of twins; how twin-twin transfusion defined | monthly US to monitor grwth and twin-twin (defined as 25% wgt discordance or AFI discordance
🗑
|
||||
| when is baby at risk for hemolytic disease of newborn | Abs are present that are assoc w hemo dz, titer at least 1:8, father is Ag +
🗑
|
||||
| if titer on indirect Coombs is 1:8, what do | repeat titer monthly and keep managing conservatively as long as stays <1:8
🗑
|
||||
| name 2 tests for determining the amt of fetal-maternal transfusion | Rosette test (+ or - if fetal-maternal hemorrhage has occurred), leihauer-Betke (acid dilution test that makes mom's RBC's pale but baby's stay red)
🗑
|
||||
| once know baby at risk for hemolytic dz of newborn, what do | determine amt of anemia by amniotic fluid (Liley graph of OD450 for amt of fetal hemolysis), or PUBS w Hct
🗑
|
||||
| when is anemia for hemolytic dz of newborn considered significant; if significant anemia in baby from hemolytic dz of newborn what do? | Liley zone III or Hct 25%; transfusion intrauterine or delivery if 34 wks
🗑
|
||||
| how much RhoGAM is given, after what events | 300ug for 30ml whole blood (15ml RBC); all Rh - at 28wks, after delivery, w/in 72 hrs of CVS, amnio, D
🗑
|
||||
| how dz ROM | must see all of: pooling of amniotic fluid in P Fornix, nitrazine paper turns blue, ferning pattern
🗑
|
||||
| risks of PROM, MC | asc infxn (MC), local defects to membranes, smoking, serial damage to membranes from cxns
🗑
|
||||
| dx of chorio | (clinical dx need all factors): maternal F, uterine tenderness w PROM but w/o evidence of URI or UTI
🗑
|
||||
| management of PROM if no chorio | <24wks (previable) induce labor or allow bed rest at home; 24-35: hospitalize w bedrest, betamethasone <32wks, obtain cerv cx, 7d prophylactic Ab and erythro; 36wks=prompt delivery
🗑
|
||||
| management of PROM if chorio | obtain cervical cx, start broad spec Abx, prompt delivery
🗑
|
||||
| risks PTL, 4 MC, 6 others | h/o preterm, uterine anomaly, mlptl gest, PROM, also smoking, heavy physical labor, pyelo, chorio, poly, abd/pelvic surgery
🗑
|
||||
| how dx PTL | 20-37 wks, 3 cxns >30sec in 30min, cervical dilation 2cm of a change in dilation or effacement
🗑
|
||||
| 4 tocolytic agents | Mg, b adrenergic (ritodrinke, terbutaline), indomethacin, CCB (nifedipine)
🗑
|
||||
| SE and mech of action of Mg as tocolytic, what do if OD | competes w Ca++ for binding sites; SE: pul edema, mscl wknss, respir depression; if OD give Ca++gluconate
🗑
|
||||
| SE and mech of action of b adrenergics as tocolytic, contraindications | (ritodrine, terbutaline): causes sm relax; SE: pul edema, hypotension, tachycardia, hyperglu, hypoK; Contraindications: cardiac dz, DM, uncontrolled hyperthyroidism
🗑
|
||||
| SE of indomethacin as tocolytic, contraindications | SE: oligo, in utero closure of PDA, NEC; Contraindications: >32 w
🗑
|
||||
| mech of action and SE of nifedipine as tocolytic, contraindications | decrses intracell Ca++, SE: hypotension, tachycardia, myocardial depression, contraindication=hypotension
🗑
|
||||
| contraindications tocolytics | fetal: fetal demise/distress, lethal anomaly; maternal: severe PreE/eclampsia, advanced cervical dilation; Placenta: SROM, severe abruptio placentae, chorio
🗑
|
||||
| management PROM | IVF w isotonic, Mg 5g IV for 20min, then 2g/h (if no contraindications for tocolytics), cervical cx and UA/Ucx before giving GBS prophylaxis (IV PCN G or erythro), IM betamethasone
🗑
|
||||
| cuases postdates | MC idiopathic, more often in young pimagravidas, rarely placental sulfatase and anenceaphaly have longest
🗑
|
||||
| 2 main risks postdates | macrosomia and dysmaturity syndrome
🗑
|
||||
| management postdates | check dates, if dates sure and favorable cervix induce; if dates sure but unfavorable either induce w PGE or manage w NST and AFI 2x/wk; unsure dates manage w NST&AFI 2x/wk
🗑
|
||||
| 3 ways to prevent mec aspiration in post dates | amnio infusion of NS, after delivery of head suction nose and pharynx; after delivery but before 2st breath aspirate neonatal tracheal mec using laryngoscope
🗑
|
||||
| def of HTN in preg | 140/90 2x at least 6hrs apart
🗑
|
||||
| chornic HTN, what good px, worst | Good outcome if £180/110, no end organ damage (Cr>1.4, HTN retinopathy, LVH), and fetal grwth is appropriate. Worst outcome if HTN_210/120
🗑
|
||||
| dx of mild preE | HTN+proteinuria (_300mg/d or 1-2+ on dipstick) w/o UTI. No HA, epigastric pain, visual changes
🗑
|
||||
| dx of severe preE | any of: 160/110, proteinuria >5g or 3+, signs of maternal jeopardy (plts <100K, hemolysis, incrsd ALT/AST, epigastric pain, persistent HA, visual disturb, pul edema, oliguria, cyanosis
🗑
|
||||
| dx of preE on top of chronic HTN | new onset proteinuria, or sudden incrs in proteinuria or BP, or any of the maternal jeopardy signs (above)
🗑
|
||||
| how often preE on top of chronic HTN, who's at risk; what preg at risk for | 25%; renal insuffic, HTN for 4 yrs, HTN in prev preg. Esp at risk for abruptio placenta
🗑
|
||||
| risks for develop preE | nulliparity young or old, mltpl gest, molar preg, nonimmune hydrops, DM, chronic HTN, renal dz, SLE/small vessel/long standing DM (esp for severe)
🗑
|
||||
| pathophys of preE | diffuse vasospasm from incrsd thromboxane and decrsd prostacyclin and decreased responsiveness to vasoactive substances, ie angiotensin causes decrsd perfusion incl fetal/plac; capillary wall injury(esp severe preE) ->vascular perm (edema, hemoconcentrat)
🗑
|
||||
| management chronic HTN in preg | monthly US >30wks to assess for IUGR (if present wkly NST or BPP); monitor maternal BP, proteinuria. Likely need to d/c HTN meds since BP decrses in preg. Rx only for severe, to keep DBP 90-100 use: methyldopa or labetalol or atenolol [NO ACEI or diuretic
🗑
|
||||
| management mild preE | <36wk in hospital conservatively as long as mom and baby are stable—keep watching for progression to severe preE. At 36wks labor is induced, sz prophylaxis MgSO4 during labor
🗑
|
||||
| management of severe PreE if no maternal jeopardy signs (what are they) and eclampsia | prompt delivery at any age if evidence of maternal or fetal jeopardy (incl HA, epigastric, visual, low plts, elev LFTs, pul ed, oliguiria or cyanosis). sz prophylaxis MgSO4 during labor, hydralazine, labetalol or nifedipine to get DBP to 90-100
🗑
|
||||
| medical/conservative management of severe preE and when used | If no signs of maternal or fetal jeopardy 26-34 wks managed in patient conservatively if BP can be brought to below 160/110; ICU w continuous IV Mg and give 2 doses of dexamethasone
🗑
|
||||
| HELLP, who more common in | HELLP=hemolysis, elevated liver enzymes, low plts. 5-10% of preE. 2x more common in multigravidas. May not have HTN
🗑
|
||||
| which pop most likely to develop HTN after preg | gestat HTN (HTN after 20wks w/o proteinuria)
🗑
|
||||
| acute fatty liver of preg, mortality rate | can resemble preE w HTN, proteinuria, edema, epigatric pain, and DIC. See hypogly and incrsd serum ammonia. Maternal mortality 50%
🗑
|
Review the information in the table. When you are ready to quiz yourself you can hide individual columns or the entire table. Then you can click on the empty cells to reveal the answer. Try to recall what will be displayed before clicking the empty cell.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
To hide a column, click on the column name.
To hide the entire table, click on the "Hide All" button.
You may also shuffle the rows of the table by clicking on the "Shuffle" button.
Or sort by any of the columns using the down arrow next to any column heading.
If you know all the data on any row, you can temporarily remove it by tapping the trash can to the right of the row.
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Created by:
ehstephns
Popular Midwifery sets